Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Personalized Care in the Prevention of Treatment-Related Cardiac Dysfunction in Female Cancer Survivors.

Pituskin E, Perri M, Cox-Kennett N, Andrews E, Dimitry R, McNeely M, Paterson I.

J Womens Health (Larchmt). 2019 Jul 17. doi: 10.1089/jwh.2018.6979. [Epub ahead of print]

PMID:
31314650
2.
3.

Cardiac Rehabilitation in Patients With Lymphoma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Cardio-oncology Pilot Project.

Rothe D, Cox-Kennett N, Buijs DM, Venner CP, Paterson DI, Gyenes GT, Pituskin E.

Can J Cardiol. 2018 Oct;34(10 Suppl 2):S263-S269. doi: 10.1016/j.cjca.2018.07.001. Epub 2018 Jul 12.

PMID:
30201254
5.

What is the minimum change in left ventricular ejection fraction, which can be measured with contrast echocardiography?

Suwatanaviroj T, He W, Pituskin E, Paterson I, Choy J, Becher H.

Echo Res Pract. 2018 Jun;5(2):71-77. doi: 10.1530/ERP-18-0003. Epub 2018 Apr 11.

6.

Does Cancer Affect Cardiac Function Prior to Cancer Therapy Exposure?

Kirkham AA, Pituskin E, Paterson DI.

Can J Cardiol. 2018 Mar;34(3):234-235. doi: 10.1016/j.cjca.2017.12.019. Epub 2017 Dec 26. No abstract available.

PMID:
29398174
7.

Variability of left ventricular volume and ejection fraction measurements using contrast echocardiography: The influence of the left ventricular length measurements in a large cohort of patients during monitoring cardiotoxic effects of chemotherapy.

Suwatanaviroj T, He W, Mirhadi E, Paakanen R, Pituskin E, Paterson I, Choy J, Becher H.

Echocardiography. 2018 Mar;35(3):322-328. doi: 10.1111/echo.13783. Epub 2017 Dec 22.

PMID:
29272561
8.

The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.

Pituskin E, Paterson I, Cox-Kennett N, Rothe D, Perri M, Becher H.

Semin Oncol Nurs. 2017 Nov;33(4):384-392. doi: 10.1016/j.soncn.2017.08.010. Epub 2017 Sep 21. Review.

PMID:
28941563
9.

Patient Perspectives on Nurse Practitioner Care in Oncology in Canada.

Stahlke S, Rawson K, Pituskin E.

J Nurs Scholarsh. 2017 Sep;49(5):487-494. doi: 10.1111/jnu.12313. Epub 2017 Jun 12.

PMID:
28605117
10.

Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study.

Spera G, Fresco R, Fung H, Dyck JRB, Pituskin E, Paterson I, Mackey JR.

Ann Oncol. 2017 Aug 1;28(8):1836-1841. doi: 10.1093/annonc/mdx264.

PMID:
28520849
11.

Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.

Pituskin E, Mackey JR, Koshman S, Jassal D, Pitz M, Haykowsky MJ, Pagano JJ, Chow K, Thompson RB, Vos LJ, Ghosh S, Oudit GY, Ezekowitz JA, Paterson DI.

J Clin Oncol. 2017 Mar 10;35(8):870-877. doi: 10.1200/JCO.2016.68.7830. Epub 2016 Nov 28.

PMID:
27893331
12.

Supporting Patients With Incurable Cancer: Backup Behavior in Multidisciplinary Cross-Functional Teams.

Huang F, Driga A, LeGuerrier BE, Schmitz R, Hall-Lavoie DM, Kostaras X, Chu KP, Pituskin E, Watanabe SM, Fairchild A.

J Oncol Pract. 2016 Nov;12(11):1123-1134. Epub 2016 Sep 30.

PMID:
27650840
13.

Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).

Pituskin E, Haykowsky M, McNeely M, Mackey J, Chua N, Paterson I.

BMC Cancer. 2016 Sep 15;16(1):733. doi: 10.1186/s12885-016-2761-8.

14.

The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.

Parent S, Pituskin E, Paterson DI.

Can J Cardiol. 2016 Jul;32(7):847-51. doi: 10.1016/j.cjca.2016.04.014. Epub 2016 May 6.

PMID:
27343743
15.

Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance.

Vos LJ, Janoski M, Wachowicz K, Yahya A, Boychak O, Amanie J, Pervez N, Parliament MB, Pituskin E, Fallone BG, Usmani N.

World J Radiol. 2016 Apr 28;8(4):410-8. doi: 10.4329/wjr.v8.i4.410.

16.

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.

Sawyer MB, Pituskin E, Damaraju S, Bies RR, Vos LJ, Prado CM, Kuzma M, Scarfe AG, Clemons M, Tonkin K, Au HJ, Koski S, Joy AA, Smylie M, King K, Carandang D, Damaraju VL, Hanson J, Cass CE, Mackey JR.

Clin Breast Cancer. 2016 Apr;16(2):139-44.e1-3. doi: 10.1016/j.clbc.2015.09.006. Epub 2015 Sep 25.

PMID:
26452313
17.

Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.

North S, Basappa N, Bjarnason G, Blais N, Canil C, Heng D, Knox J, Reaume N, Ruether D, Soulières D, Zalewski P, Black P, Breau RH, Jewett M, Kapoor A, Lattouf JB, Moore R, Rendon R, Todd G, Pituskin E, Gedye C, Wood L.

Can Urol Assoc J. 2013 Jul-Aug;7(7-8):238-43. doi: 10.5489/cuaj.536. No abstract available. Erratum in: Can Urol Assoc J. 2013 Nov;7(11-12):E780. Breau, Rodney [corrected to Breau, Rodney H].

18.

PI3K inhibitors as novel cancer therapies: implications for cardiovascular medicine.

McLean BA, Zhabyeyev P, Pituskin E, Paterson I, Haykowsky MJ, Oudit GY.

J Card Fail. 2013 Apr;19(4):268-82. doi: 10.1016/j.cardfail.2013.02.005. Review.

PMID:
23582093
19.

Improving access to specialist multidisciplinary palliative care consultation for rural cancer patients by videoconferencing: report of a pilot project.

Watanabe SM, Fairchild A, Pituskin E, Borgersen P, Hanson J, Fassbender K.

Support Care Cancer. 2013 Apr;21(4):1201-7. doi: 10.1007/s00520-012-1649-7. Epub 2012 Nov 17.

PMID:
23161339
20.

Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.

Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, Hornsby WE, Coan AD, Herndon JE 2nd, Douglas PS, Haykowsky M.

J Clin Oncol. 2012 Jul 10;30(20):2530-7. doi: 10.1200/JCO.2011.39.9014. Epub 2012 May 21.

21.

Management of kidney cancer: canadian kidney cancer forum consensus update 2011.

Jewett M, Finelli A, Kollmannsberger C, Wood L, Legere L, Basiuk J, Canil C, Heng D, Reaume N, Tanguay S, Atkins M, Bjarnason G, Dancey J, Evans M, Fleshner N, Haider M, Kapoor A, Uzzo R, Maskens D, Soulieres D, Yousef G, Basappa N, Bendali N, Black P, Blais N, Cagiannos I, Care M, Chow R, Chung H, Czaykowski P, Derosa D, Durrant K, Ellard S, Farquharson G, Filion-Brulotte C, Gingerich J, Godbout L, Grant R, Hamilton W, Kassouf W, Kurban G, Lane K, Lattouf J, Lau D, Leveridge M, McCarthy J, Moore R, North S, O'brien P, Pituskin E, Racine P, Rendon R, So A, Sridhar S, Stubbs K, Su Z, Taylor L, Udall T, Venner P, Vogel W, Yap S, Yau P, Cooper M, Giroux N, Miron D, Mosher D, Ross K, Willacy J.

Can Urol Assoc J. 2012 Feb;6(1):16-22. doi: 10.5489/cuaj.11273. No abstract available.

23.

Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: contributions of a clinical pharmacist.

Gagnon L, Fairchild A, Pituskin E, Dutka J, Chambers C.

J Oncol Pharm Pract. 2012 Mar;18(1):76-83. doi: 10.1177/1078155211402104. Epub 2011 Apr 13.

PMID:
21490115
24.

Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis.

Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, Haykowsky M.

Oncologist. 2011;16(1):112-20. doi: 10.1634/theoncologist.2010-0197. Epub 2011 Jan 6. Review. Erratum in: Oncologist. 2011;16(2):260.

25.

The Feasibility of Telephone Follow-up Led by a Radiation Therapist: Experience in a Multidisciplinary Bone Metastases Clinic.

Dixon W, Pituskin E, Fairchild A, Ghosh S, Danielson B.

J Med Imaging Radiat Sci. 2010 Dec;41(4):175-179. doi: 10.1016/j.jmir.2010.10.003. Epub 2010 Dec 15.

PMID:
31051877
26.

Multidisciplinary team contributions within a dedicated outpatient palliative radiotherapy clinic: a prospective descriptive study.

Pituskin E, Fairchild A, Dutka J, Gagnon L, Driga A, Tachynski P, Borschneck JA, Ghosh S.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):527-32. doi: 10.1016/j.ijrobp.2009.07.1698. Epub 2010 Jan 25.

PMID:
20100640
27.

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.

Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB.

Clin Cancer Res. 2009 Apr 15;15(8):2920-6. doi: 10.1158/1078-0432.CCR-08-2242. Epub 2009 Apr 7.

28.

The rapid access palliative radiotherapy program: blueprint for initiation of a one-stop multidisciplinary bone metastases clinic.

Fairchild A, Pituskin E, Rose B, Ghosh S, Dutka J, Driga A, Tachynski P, Borschneck J, Gagnon L, Macdonnell S, Middleton J, Thavone K, Carstairs S, Brent D, Severin D.

Support Care Cancer. 2009 Feb;17(2):163-70. doi: 10.1007/s00520-008-0468-3. Epub 2008 Jun 20.

PMID:
18566840
29.

Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer.

Jones LW, Haykowsky M, Pituskin EN, Jendzjowsky NG, Tomczak CR, Haennel RG, Mackey JR.

Oncologist. 2007 Oct;12(10):1156-64.

30.

Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab.

Jones LW, Haykowsky M, Peddle CJ, Joy AA, Pituskin EN, Tkachuk LM, Courneya KS, Slamon DJ, Mackey JR.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):1026-31.

31.
32.

A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration.

Bruera E, Neumann CM, Pituskin E, Calder K, Hanson J.

Ann Oncol. 1999 Oct;10(10):1255-8.

PMID:
10586347
33.

Thalidomide in patients with cachexia due to terminal cancer: preliminary report.

Bruera E, Neumann CM, Pituskin E, Calder K, Ball G, Hanson J.

Ann Oncol. 1999 Jul;10(7):857-9. No abstract available.

PMID:
10470435
34.

Telephone triage in acute oncology.

Chobanuk J, Pituskin E, Kashuba L, Bates J.

Can Nurse. 1999 Jan;95(1):30-2.

PMID:
10401272
35.

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.

Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, Babul N, Ford I.

J Clin Oncol. 1998 Oct;16(10):3222-9.

PMID:
9779695

Supplemental Content

Loading ...
Support Center